Abraxis Bioscience announced the appointment of Rick Rodgers as Senior Vice President and Chief Financial Officer, succeeding David O'Toole. Rodgers most recently was Senior Vice President, Controller and Chief Accounting Officer of MGI Pharma until the company's acquisition by the Eisai Corporation in 2008.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
This interview covers key results of the study ‘Success Factor Supply Chain Management and Logistics in the Chemical Industry 2024’ by Solventure, Aimms and Miebach.
Valerie Diele-Braun resigned from her position as CEO and member of the Executive Board of IMCD at the end of April for personal reasons.
Jens Birgersson becomes new Brenntag CEO
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.
